Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhu Simcere Pharmaceutical, a subsidiary of Simcere Pharmaceutical Group, is a specialized pharmaceutical company based in Wuhu, China, focusing on sustained-release drug delivery systems. The company is globally recognized for its reproductive health portfolio, particularly the Sino-implant (II) (also known as Levoplant), a long-acting reversible contraceptive implant containing levonorgestrel. Beyond contraception, Wuhu Simcere develops and manufactures specialized formulations including transdermal patches for pain management and sustained-release implants for oncology. The company's manufacturing facilities adhere to international quality standards, enabling it to supply essential medicines to global health organizations and family planning programs. As part of the Simcere Group, it leverages extensive R&D resources to advance its delivery technology and expand its product reach in both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhu Simcere Sino-implant Pharmaceutical.